GRDN financials
Guardian Pharmacy (GRDN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
GRDN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.45B | $282.04M | $88.91M | $49.22M | 0.78 |
| 2024 | $1.23B | $244.37M | -$62.92M | -$87.29M | -1.77 |
| 2023 | $1.05B | $208.31M | $40.95M | $23.90M | 0.39 |
| 2022 | $908.91M | $185.87M | $51.99M | $35.42M | 0.58 |
| 2021 | $792.07M | $161.26M | $30.15M | $16.31M | 0.27 |
| 2020 | $735.96M | $147.00M | $32.06M | $19.94M | 0.33 |
- GRDN revenue was $1.45B in fiscal 2025, net income $49.22M.
Updated 2026-11-07 11:55 UTC